Deschloroclozapine exhibits an exquisite agonistic effect at lower concentration compared to clozapine-N-oxide in hM3Dq expressing chemogenetically modified rats.

MLA

Shimizu, Makiko, et al. “Deschloroclozapine Exhibits an Exquisite Agonistic Effect at Lower Concentration Compared to Clozapine-N-Oxide in HM3Dq Expressing Chemogenetically Modified Rats.” Frontiers in Neuroscience, vol. 17, Nov. 2023, p. 1301515. EBSCOhost, https://doi.org/10.3389/fnins.2023.1301515.

APA

Shimizu, M., Yoshimura, M., Baba, K., Ikeda, N., Nonaka, Y., Maruyama, T., Onaka, T., & Ueta, Y. (2023). Deschloroclozapine exhibits an exquisite agonistic effect at lower concentration compared to clozapine-N-oxide in hM3Dq expressing chemogenetically modified rats. Frontiers in Neuroscience, 17, 1301515. https://doi.org/10.3389/fnins.2023.1301515

Chicago

Shimizu, Makiko, Mitsuhiro Yoshimura, Kazuhiko Baba, Naofumi Ikeda, Yuki Nonaka, Takashi Maruyama, Tatsushi Onaka, and Yoichi Ueta. 2023. “Deschloroclozapine Exhibits an Exquisite Agonistic Effect at Lower Concentration Compared to Clozapine-N-Oxide in HM3Dq Expressing Chemogenetically Modified Rats.” Frontiers in Neuroscience 17 (November): 1301515. doi:10.3389/fnins.2023.1301515.